Valar Labs scores FDA breakthrough tag for AI‑based bladder cancer risk test on May 18, 2026 Bladder Risk Breakthrough Device Designation digital pathology prognostic test hematoxylin and eosin ( H&E ) stained Stratify Dx United States Food and Drug Administration Valar Labs Vesta <beetles> +